Basile Edward M's Form 4 filing
TransMedics Group, Inc. (TMDX) · filed May 8, 2024
- Accession no.
- 0000950170-24-055798
- Filed
- May 8, 2024
- Trade date
- May 7, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions and 0 derivative transactions. Open-market sales total $930.3K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Basile Edward MCIK 0001773661 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 7, 2024 | Common Stock | SSaleDisposed | −2,130 | $128.43 | −$273,555.9 | 6,220 | Direct | |
| May 7, 2024 | Common Stock | SSaleDisposed | −2,226 | $129.80 | −$288,934.8 | 3,994 | Direct | |
| May 7, 2024 | Common Stock | SSaleDisposed | −885 | $130.31 | −$115,324.35 | 3,109 | Direct | |
| May 7, 2024 | Common Stock | SSaleDisposed | −1,100 | $131.34 | −$144,474 | 2,009 | Direct | |
| May 7, 2024 | Common Stock | SSaleDisposed | −816 | $132.34 | −$107,989.44 | 1,193 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.